Takeuchi K - Search Results

1

Eosinophil-rich variant of nodal marginal zone lymphoma: a clinicopathological study of 11 cases.

Miyake M, Sakata S, Tsuyama N, Togashi Y, Noguchi M, Tsukada N, Kumagai T, Mishima Y, Takeuchi K. Miyake M, et al. Among authors: takeuchi k. Histopathology. 2023 Sep;83(3):443-452. doi: 10.1111/his.14963. Epub 2023 May 24. Histopathology. 2023. PMID: 37222201

2

Monitoring serum hepatitis C virus (HCV) RNA in patients with HCV-infected CD20-positive B-cell lymphoma undergoing rituximab combination chemotherapy.

Ennishi D, Terui Y, Yokoyama M, Mishima Y, Takahashi S, Takeuchi K, Okamoto H, Tanimoto M, Hatake K. Ennishi D, et al. Among authors: takeuchi k. Am J Hematol. 2008 Jan;83(1):59-62. doi: 10.1002/ajh.21022. Am J Hematol. 2008. PMID: 17712791 Free article.

3

EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers.

Inamura K, Takeuchi K, Togashi Y, Nomura K, Ninomiya H, Okui M, Satoh Y, Okumura S, Nakagawa K, Soda M, Choi YL, Niki T, Mano H, Ishikawa Y. Inamura K, et al. Among authors: takeuchi k. J Thorac Oncol. 2008 Jan;3(1):13-7. doi: 10.1097/JTO.0b013e31815e8b60. J Thorac Oncol. 2008. PMID: 18166835 Free article.

4

Increased incidence of interstitial pneumonia by CHOP combined with rituximab.

Ennishi D, Terui Y, Yokoyama M, Mishima Y, Takahashi S, Takeuchi K, Ikeda K, Tanimoto M, Hatake K. Ennishi D, et al. Among authors: takeuchi k. Int J Hematol. 2008 May;87(4):393-397. doi: 10.1007/s12185-008-0066-7. Int J Hematol. 2008. PMID: 18409079

5

CD5 expression is potentially predictive of poor outcome among biomarkers in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP therapy.

Ennishi D, Takeuchi K, Yokoyama M, Asai H, Mishima Y, Terui Y, Takahashi S, Komatsu H, Ikeda K, Yamaguchi M, Suzuki R, Tanimoto M, Hatake K. Ennishi D, et al. Among authors: takeuchi k. Ann Oncol. 2008 Nov;19(11):1921-6. doi: 10.1093/annonc/mdn392. Epub 2008 Jun 23. Ann Oncol. 2008. PMID: 18573805 Free article.

6

Multiplex reverse transcription-PCR screening for EML4-ALK fusion transcripts.

Takeuchi K, Choi YL, Soda M, Inamura K, Togashi Y, Hatano S, Enomoto M, Takada S, Yamashita Y, Satoh Y, Okumura S, Nakagawa K, Ishikawa Y, Mano H. Takeuchi K, et al. Clin Cancer Res. 2008 Oct 15;14(20):6618-24. doi: 10.1158/1078-0432.CCR-08-1018. Clin Cancer Res. 2008. PMID: 18927303

7

Soluble interleukin-2 receptor retains prognostic value in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP (RCHOP) therapy.

Ennishi D, Yokoyama M, Terui Y, Asai H, Sakajiri S, Mishima Y, Takahashi S, Komatsu H, Ikeda K, Takeuchi K, Tanimoto M, Hatake K. Ennishi D, et al. Among authors: takeuchi k. Ann Oncol. 2009 Mar;20(3):526-33. doi: 10.1093/annonc/mdn677. Epub 2008 Dec 12. Ann Oncol. 2009. PMID: 19074749 Free article.

8

EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset.

Inamura K, Takeuchi K, Togashi Y, Hatano S, Ninomiya H, Motoi N, Mun MY, Sakao Y, Okumura S, Nakagawa K, Soda M, Choi YL, Mano H, Ishikawa Y. Inamura K, et al. Among authors: takeuchi k. Mod Pathol. 2009 Apr;22(4):508-15. doi: 10.1038/modpathol.2009.2. Epub 2009 Feb 20. Mod Pathol. 2009. PMID: 19234440 Free article.

9

Identification of CD20 C-terminal deletion mutations associated with loss of CD20 expression in non-Hodgkin's lymphoma.

Terui Y, Mishima Y, Sugimura N, Kojima K, Sakurai T, Mishima Y, Kuniyoshi R, Taniyama A, Yokoyama M, Sakajiri S, Takeuchi K, Watanabe C, Takahashi S, Ito Y, Hatake K. Terui Y, et al. Among authors: takeuchi k. Clin Cancer Res. 2009 Apr 1;15(7):2523-30. doi: 10.1158/1078-0432.CCR-08-1403. Epub 2009 Mar 10. Clin Cancer Res. 2009. PMID: 19276251

10

KIF5B-ALK, a novel fusion oncokinase identified by an immunohistochemistry-based diagnostic system for ALK-positive lung cancer.

Takeuchi K, Choi YL, Togashi Y, Soda M, Hatano S, Inamura K, Takada S, Ueno T, Yamashita Y, Satoh Y, Okumura S, Nakagawa K, Ishikawa Y, Mano H. Takeuchi K, et al. Clin Cancer Res. 2009 May 1;15(9):3143-9. doi: 10.1158/1078-0432.CCR-08-3248. Epub 2009 Apr 21. Clin Cancer Res. 2009. PMID: 19383809

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,233 results

Search Page